Crohn's disease Trials in Great Neck, United States
Conditions / Crohn's disease / Great Neck, United States
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
74 total trials for this combination
Showing top 10 of 74 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03105102 | A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02914561 | Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT06430801 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | RECRUITING | — |
| NCT01369342 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) | COMPLETED | PHASE3 |
| NCT02914600 | Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease | TERMINATED | PHASE3 |
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03105128 | A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT01369355 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) | COMPLETED | PHASE3 |
| NCT03104413 | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment | COMPLETED | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |